LifeTECH Scientific Abstract to be Present at International Society for Antiviral Research Conference TORONTO, April 10 1997 - LifeTECH Corporation today announced the acceptance of a key scientific abstract at the International Society for Antiviral Research Conference to be held on April 10, 1997 in Atlanta, Georgia. The abstract is entitled "Inactivation of Enveloped and Non-Enveloped Viruses by Ozone Induced Oxidative Stress." Its principal author is Dr. Peter Lea, LifeTECH's Director of Research and Development. The announcement was made by Mr. Walter J. Dermott, President & CEO, who said "The acceptance of another LifeTECH abstract at an important international congress reflects the rapid pace of our scientific advances. The unique ability of our Sterinetics(TM) System to inactivate viruses in blood and blood products has now been recognized by scientific symposiums around the world. Our research and development will position the Sterinetics System as the only viable sterilization technology that can make the global blood supply safer." The abstract describes the dramatic progress achieved by the Sterinetics System in the sterilization of blood and blood products. LifeTECH's research has confirmed the successful inactivation in human immunoglobulin of 6 logs/ml of two enveloped viruses - Infectious Bovine Rhinotracheitis, a large herpes virus and Bovine Viral Diarrhea, which models the human Hepatitis C virus - and Bovine Adenovirus, a non-enveloped virus. Of critical importance was the finding that the human immunoglobulin was fully functional after the application of controlled oxidative stress, verifying its suitability for transfusion purposes. The International Society for Antiviral Research is based in the Janssen Research Foundation, Beerse, Belgium and provides an interdisciplinary forum for scientific investigators involved in basic, applied and clinical research in all areas of antiviral research.